Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00273273 · ClinicalTrials.gov registry record
PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 30
- Enrollment target
NCT00273273 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 30 participants.
The verdict
NCT00273273 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this project is to study the pharmacokinetics of a once-daily antiretroviral medication used to treat adolescents and young adults with HIV infection.
Interventions
- PROCEDURE blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-02 |
| Est. Completion | 2007-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00273273
The ClinicalTrials.gov registry entry for NCT00273273 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which blood draw is the first listed.
NCT00273273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00273273 about?
NCT00273273 is a clinical study titled "PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir". The purpose of this project is to study the pharmacokinetics of a once-daily antiretroviral medication used to treat adolescents and young adults with HIV infection.
What is the current status of trial NCT00273273?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-02. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00273273?
The interventions under investigation include: blood draw (PROCEDURE).
Who is sponsoring clinical trial NCT00273273?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.